95 related articles for article (PubMed ID: 7238585)
1. Secoverine selectively antagonizes muscarinic effects in various in vivo preparations.
Zwagemakers JM; Claassen V
Eur J Pharmacol; 1981 Apr; 71(1):165-8. PubMed ID: 7238585
[TBL] [Abstract][Full Text] [Related]
2. Secoverine is a non-selective muscarinic antagonist on rat heart and brain receptors.
Brunner F; Waelbroeck M; Christophe J
Eur J Pharmacol; 1986 Aug; 127(1-2):17-25. PubMed ID: 3758175
[TBL] [Abstract][Full Text] [Related]
3. Effect of secoverine and atropine on intestinal secretion and motor activity in the rat small intestine in-vivo.
Greenwood B; Read NW; Hardcastle PT; Hardcastle J
J Pharm Pharmacol; 1984 Feb; 36(2):100-6. PubMed ID: 6143792
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 1: Antimuscarinic and spasmolytic effects.
Zwagemakers JM; Claassen V
Arzneimittelforschung; 1980; 30(9):1517-26. PubMed ID: 7193020
[TBL] [Abstract][Full Text] [Related]
5. In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine.
Howell G; West L; Jenkins C; Lineberry B; Yokum D; Rockhold R
BMC Pharmacol; 2005 Aug; 5():13. PubMed ID: 16109168
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor binding and the effect of atropine on the guinea-pig iris.
Karlsen RL
Exp Eye Res; 1978 Nov; 27(5):577-83. PubMed ID: 720431
[No Abstract] [Full Text] [Related]
7. The effects of atropine and secoverine on gastric secretion and motility in the mouse isolated stomach.
Davison JS; Greenwood B; Najafi-Farashah A; Read NW
Br J Pharmacol; 1983 Jun; 79(2):525-9. PubMed ID: 6652343
[TBL] [Abstract][Full Text] [Related]
8. A comparison of muscarinic cholinergic involvement in the antinociceptive effects of morphine and clonidine in the mouse.
Lipman JJ; Spencer PS
Eur J Pharmacol; 1980 Jun; 64(4):249-58. PubMed ID: 7389822
[TBL] [Abstract][Full Text] [Related]
9. Central muscarinic receptors signal pilocarpine-induced salivation.
Takakura AC; Moreira TS; Laitano SC; De Luca Júnior LA; Renzi A; Menani JV
J Dent Res; 2003 Dec; 82(12):993-7. PubMed ID: 14630901
[TBL] [Abstract][Full Text] [Related]
10. Enantiomers of oxybutynin: in vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs.
Noronha-Blob L; Kachur JF
J Pharmacol Exp Ther; 1991 Feb; 256(2):562-7. PubMed ID: 1993995
[TBL] [Abstract][Full Text] [Related]
11. Types of muscarinic response in Xenopus oocytes.
Dascal N; Landau EM
Life Sci; 1980 Oct; 27(15):1423-8. PubMed ID: 7442451
[No Abstract] [Full Text] [Related]
12. Analysis of regional variations in the affinities of muscarinic agonists in the rat brain.
Ellis J; Hoss W
Brain Res; 1980 Jul; 193(1):189-98. PubMed ID: 7378815
[No Abstract] [Full Text] [Related]
13. Enhancement by secoverine and physostigmine of retention of passive avoidance response in mice.
Gower AJ
Psychopharmacology (Berl); 1987; 91(3):326-9. PubMed ID: 3104954
[TBL] [Abstract][Full Text] [Related]
14. Agonist specific effects of guanine nucleotides on muscarinic cholinergic receptors in rat anterior pituitary membranes.
Mukherjee A; Snyder GD
Biochim Biophys Acta; 1981 Apr; 674(1):160-5. PubMed ID: 7236727
[TBL] [Abstract][Full Text] [Related]
15. Atropine and mepenzolate mydriasis in rabbits: a comparative pupillographic analysis of two antimuscarinic agents.
Ochillo RF; Pugh DA
Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):503-6. PubMed ID: 7122991
[TBL] [Abstract][Full Text] [Related]
16. Alterations of muscarinic cholinergic receptors in the rat striatum after kainic acid injections.
Hruska RE; Schwarcz R; Coyle JT; Yamamura HI
Brain Res; 1978 Sep; 152(3):620-5. PubMed ID: 687979
[No Abstract] [Full Text] [Related]
17. Cholinergic muscarinic binding by rat lymphocytes: effects of antagonist treatment, strain and aging.
Shenkman L; Rabey JM; Gilad GM
Brain Res; 1986 Aug; 380(2):303-8. PubMed ID: 3756482
[TBL] [Abstract][Full Text] [Related]
18. On the presence in the cerebral cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties.
Marchi M; Raiteri M
J Pharmacol Exp Ther; 1985 Oct; 235(1):230-3. PubMed ID: 3840202
[TBL] [Abstract][Full Text] [Related]
19. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ
Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648
[TBL] [Abstract][Full Text] [Related]
20. [Muscarinic receptors].
Burgen AS
Actual Pharmacol (Paris); 1977; 29():143-54. PubMed ID: 868615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
